Please provide your email address to receive an email when new articles are posted on . The approval and commercialization of Oxervate (cenegermin-bkbj, Dompé) in the United States has improved our ...
In this figure you can see all of the diseases that were identified linked to epithelial barrier defect and microbial dysbiosis linked to epithelial barrier damaging environmental substances In this ...
DelveInsight's “Persistent Corneal Epithelial Defects Pipeline Insight 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Persistent Corneal Epithelial Defects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results